BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 38140019)

  • 1. Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis.
    Hasan M; Khatun A; Kogure K
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive Intradermal Delivery of Hyaluronic Acid via Iontophoresis.
    Inoue S; Oshima Y; Kogure K
    Biol Pharm Bull; 2023; 46(11):1635-1638. PubMed ID: 37914367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
    Fukuta T; Tanaka D; Inoue S; Michiue K; Kogure K
    Int J Pharm; 2021 Jun; 602():120601. PubMed ID: 33905867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive delivery of biological macromolecular drugs into the skin by iontophoresis and its application to psoriasis treatment.
    Fukuta T; Oshima Y; Michiue K; Tanaka D; Kogure K
    J Control Release; 2020 Jul; 323():323-332. PubMed ID: 32360305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Effective Psoriasis Treatment by Combining Tacrolimus-Encapsulated Liposomes and Iontophoresis.
    Nakamura S; Ozono M; Yanagi K; Kogure K
    Biol Pharm Bull; 2024; 47(1):196-203. PubMed ID: 38246645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive transdermal delivery of liposomes by weak electric current.
    Hasan M; Khatun A; Fukuta T; Kogure K
    Adv Drug Deliv Rev; 2020; 154-155():227-235. PubMed ID: 32589904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Iontophoresis Technology for Transdermal Delivery of a Minimal mRNA Vaccine as a Potential Melanoma Therapeutic.
    Husseini RA; Abe N; Hara T; Abe H; Kogure K
    Biol Pharm Bull; 2023; 46(2):301-308. PubMed ID: 36724958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Skeletal Muscle Mass in Mice by Non-Invasive Intramuscular Delivery of Myostatin Inhibitory Peptide by Iontophoresis.
    Michiue K; Takayama K; Taniguchi A; Hayashi Y; Kogure K
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Noninvasive Delivery of mRNA.
    Qin M; Du G; Sun X
    Acc Chem Res; 2021 Dec; 54(23):4262-4271. PubMed ID: 34756014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal delivery of vaccines: potential benefits and current challenges.
    Hickling JK; Jones KR; Friede M; Zehrung D; Chen D; Kristensen D
    Bull World Health Organ; 2011 Mar; 89(3):221-6. PubMed ID: 21379418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
    Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
    J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal delivery of mRNA using cryomicroneedles.
    Yu J; Kuwentrai C; Gong HR; Li R; Zhang BZ; Lin X; Wang X; Huang JD; Xu C
    Acta Biomater; 2022 Aug; 148():133-141. PubMed ID: 35697200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device.
    Beyers KCL; Rbeihat MNM; S Vasconcelos D; Pasmans D; Verwulgen S; Vankerckhoven VVJ
    Vaccine; 2023 Jul; 41(31):4609-4615. PubMed ID: 37330370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
    Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
    Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for transcutaneous vaccination.
    Hansen S; Lehr CM
    Microb Biotechnol; 2012 Mar; 5(2):156-67. PubMed ID: 21854553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
    Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
    Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug Delivery to Various Body Organs via Non-blood Circulatory Pathway].
    Kogure K; Fukuta T
    Yakugaku Zasshi; 2020; 140(5):611-615. PubMed ID: 32378660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery.
    Engelke L; Winter G; Engert J
    Eur J Pharm Biopharm; 2018 Jul; 128():119-130. PubMed ID: 29660407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.
    Golombek S; Pilz M; Steinle H; Kochba E; Levin Y; Lunter D; Schlensak C; Wendel HP; Avci-Adali M
    Mol Ther Nucleic Acids; 2018 Jun; 11():382-392. PubMed ID: 29858073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.